Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated with worse COVID-19 outcome. However, whether specific population can be at higher risk of viremia are to date unexplored.

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

Cento, Valeria;
2021-01-01

Abstract

Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated with worse COVID-19 outcome. However, whether specific population can be at higher risk of viremia are to date unexplored.
2021
COVID-19
Hematological malignancies
Molecular diagnosis
SARS-CoV-2
Viremia
ddPCR
Adult
Aged
COVID-19
COVID-19 Nucleic Acid Testing
Cross-Sectional Studies
Female
Humans
Male
Middle Aged
Prognosis
Proof of Concept Study
RNA, Viral
SARS-CoV-2
Serologic Tests
Viral Load
Viremia
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/65909
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 22
social impact